Determining the significance of MGUS

被引：11
作者：
Merlini, Giampaolo [1 ]
机构：
[1] Univ Pavia, I-27100 Pavia, Italy
来源：
BLOOD | 2014年 / 123卷 / 03期
关键词：
LIGHT-CHAIN AMYLOIDOSIS; MONOCLONAL GAMMOPATHY; UNDETERMINED SIGNIFICANCE; MULTIPLE-MYELOMA; RISK-FACTOR; PROGRESSION;
D O I：
10.1182/blood-2013-12-539940
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：305 / 307
页数：5
相关论文
共 11 条
[1]   Patients with immunoglobulin light chain amyloidosis undergoing autologous stem cell transplantation have superior outcomes compared with patients with multiple myeloma: a retrospective review from a tertiary referral center. [J].
Dispenzieri, A. ;
Seenithamby, K. ;
Lacy, M. Q. ;
Kumar, S. K. ;
Buadi, F. K. ;
Hayman, S. R. ;
Dingli, D. ;
Litzow, M. R. ;
Gastineau, D. A. ;
Inwards, D. J. ;
Micallef, I. N. ;
Ansell, S. M. ;
Johnston, P. B. ;
Porrata, L. F. ;
Patnaik, M. M. ;
Hogan, W. J. ;
Gertz, M. A. A. .
BONE MARROW TRANSPLANTATION, 2013, 48 (10) :1302-1307
[2]  
Dispenzieri A, 2013, BLOOD
[3]   Suppression of uninvolved immunoglobulins defined by heavy/light chain pair suppression is a risk factor for progression of MGUS [J].
Katzmann, J. A. ;
Clark, R. ;
Kyle, R. A. ;
Larson, D. R. ;
Therneau, T. M. ;
Melton, L. J., III ;
Benson, J. T. ;
Colby, C. L. ;
Dispenzieri, A. ;
Landgren, O. ;
Kumar, S. ;
Bradwell, A. R. ;
Cerhan, J. R. ;
Rajkumar, S. V. .
LEUKEMIA, 2013, 27 (01) :208-212
[4]   Monoclonal gammopathy of undetermined significance (MGUS) and smoldering (asymptomatic) multiple myeloma: IMWG consensus perspectives risk factors for progression and guidelines for monitoring and management [J].
Kyle, R. A. ;
Durie, B. G. M. ;
Rajkumar, S. V. ;
Landgren, O. ;
Blade, J. ;
Merlini, G. ;
Kroeger, N. ;
Einsele, H. ;
Vesole, D. H. ;
Dimopoulos, M. ;
San Miguel, J. ;
Avet-Loiseau, H. ;
Hajek, R. ;
Chen, W. M. ;
Anderson, K. C. ;
Ludwig, H. ;
Sonneveld, P. ;
Pavlovsky, S. ;
Palumbo, A. ;
Richardson, P. G. ;
Barlogie, B. ;
Greipp, P. ;
Vescio, R. ;
Turesson, I. ;
Westin, J. ;
Boccadoro, M. .
LEUKEMIA, 2010, 24 (06) :1121-1127
[5]   Monoclonal gammopathy of renal significance: when MGUS is no longer undetermined or insignificant [J].
Leung, Nelson ;
Bridoux, Frank ;
Hutchison, Colin A. ;
Nasr, Samih H. ;
Cockwell, Paul ;
Fermand, Jean-Paul ;
Dispenzieri, Angela ;
Song, Kevin W. ;
Kyle, Robert A. .
BLOOD, 2012, 120 (22) :4292-4295
[6]   Lenalidomide plus Dexamethasone for High-Risk Smoldering Multiple Myeloma [J].
Mateos, Maria-Victoria ;
Hernandez, Miguel-Teodoro ;
Giraldo, Pilar ;
de la Rubia, Javier ;
de Arriba, Felipe ;
Lopez Corral, Lucia ;
Rosinol, Laura ;
Paiva, Bruno ;
Palomera, Luis ;
Bargay, Joan ;
Oriol, Albert ;
Prosper, Felipe ;
Lopez, Javier ;
Olavarria, Eduardo ;
Quintana, Nuria ;
Garcia, Jose-Luis ;
Blade, Joan ;
Lahuerta, Juan-Jose ;
San Miguel, Jesus-F. .
NEW ENGLAND JOURNAL OF MEDICINE, 2013, 369 (05) :438-447
[7]   Differential diagnosis of monoclonal gammopathy of undetermined significance [J].
Merlini, Giampaolo ;
Palladini, Giovanni .
HEMATOLOGY-AMERICAN SOCIETY OF HEMATOLOGY EDUCATION PROGRAM, 2012, :595-603
[8]   Systemic light chain amyloidosis: an update for treating physicians [J].
Merlini, Giampaolo ;
Wechalekar, Ashutosh D. ;
Palladini, Giovanni .
BLOOD, 2013, 121 (26) :5124-5130
[9]   Serum free light chain ratio is an independent risk factor for progression in monoclonal gammopathy of undetermined significance [J].
Rajkumar, SV ;
Kyle, RA ;
Therneau, TM ;
Melton, LJ ;
Bradwell, AR ;
Clark, RJ ;
Larson, DR ;
Plevak, MF ;
Dispenzieri, A ;
Katzmann, JA .
BLOOD, 2005, 106 (03) :812-817
[10]   Incidence of Monoclonal Gammopathy of Undetermined Significance and Estimation of Duration Before First Clinical Recognition [J].
Therneau, Terry M. ;
Kyle, Robert A. ;
Melton, L. Joseph, III ;
Larson, Dirk R. ;
Benson, Joanne T. ;
Colby, Colin L. ;
Dispenzieri, Angela ;
Kumar, Shaji ;
Katzmann, Jerry A. ;
Cerhan, James R. ;
Rajkumar, S. Vincent .
MAYO CLINIC PROCEEDINGS, 2012, 87 (11) :1071-1079
12